Open AccessElevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes
Author(s) -
Srikanth Bellary,
Jeffrey Faint,
Lakhvir K. Assi,
Colin A. Hutchison,
Stephen J. Harding,
Neil T. Raymond,
Anthony Barnett
Publication year - 2014
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc13-2227
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , odds ratio , creatinine , gastroenterology , logistic regression , endocrinology
Elevated polyclonal serum immunoglobulin free light chains (FLCs; combined FLCκ+FLCλ [cFLC]) are associated with adverse clinical outcomes and increased mortality; we investigated cFLC and cardiovascular disease (CVD) events in type 2 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom